Proteomic studies have identified thousands of protein changes in human Alzheimer’s disease brain tissue, offering significant opportunities for therapeutic and biomarker discovery. In this review, we discuss the current proteomic landscape of Alzheimer’s disease brain tissue, detailing protein changes across disease stages, brain regions, and neuropathological lesions (amyloid plaques, neurofibrillary tangles and cerebral amyloid angiopathy). By performing a combined analysis of 53 proteomics studies of human Alzheimer’s disease brain tissue, we highlight proteins of particular interest for future studies including highly reproducible protein changes across many studies, proteins altered in preclinical Alzheimer’s disease, and proteins significantly enriched in neuropathological lesions. This combined analysis revealed early synaptic vulnerability, progressive mitochondrial dysfunction and glial activation, and the prominent involvement of extracellular, glycosaminoglycan-binding proteins in amyloid plaques. We discuss key considerations for prioritising proteomic hits for drug discovery including disease relevance, safety considerations, assayability, and how protein structure can influence druggability. We discuss the careful consideration required for selecting an appropriate animal or cell model of Alzheimer’s disease for functional studies of proteomic hits and drug screening. We detail the strengths and limitations of several commonly used Alzheimer’s disease models including transgenic mouse models, iPSC derived cells, 3D cell cultures, organoids and emerging neurovascular organ-on-a-chip systems. Together, this review outlines a roadmap for translating proteomic discoveries into clinically meaningful therapies.
Category: biotech/medical – Page 38
Radioimmunotherapy (RIT) in AML Transplant Conditioning: Can Radiation Be Targeted to Leukemia?
Reduced-intensity conditioning (RIC) has made allogeneic hematopoietic cell transplantation (allo-HCT) accessible to older patients and those who can’t tolerate myeloablative conditioning. The trade-off is less pre-transplant cytoreduction, and relapse remains a major limitation, especially in acute myeloid leukemia with adverse molecular or cytogenetic features and in patients who are MRD-positive at transplant.
Radioimmunotherapy (RIT) is being explored as a way to intensify leukemia-directed radiation without proportionally increasing radiation exposure to nonhematopoietic organs. A monoclonal antibody recognizes an antigen expressed in the hematopoietic compartment and carries a therapeutic radionuclide to the marrow, spleen and other sites of disease. It can be incorporated into an RIC transplant regimen.
The biological rationale, clinical experience, and emerging α-emitter platforms are reviewed in Frontiers. The clinical evidence remains early phase, but it shows that substantial radiation doses can be concentrated in hematopoietic tissues with reliable donor engraftment.
Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials
The open-label extension of the OPERA I and II randomized clinical trials assesses 10-year safety and efficacy of ocrelizumab in patients with relapsing multiple sclerosis.
Patient-derived tissue cultures complement neurospheres for preclinical evaluation of AAV-mediated gene delivery in glioblastoma
Glioblastoma (GBM) is characterized by extensive intratumoral heterogeneity and a complex tumor microenvironment that complicate the preclinical evaluation of gene therapy vectors. We investigated how culture model, epidermal growth factor (EGF) supplementation, and adeno-associated virus (AAV) serotype influence vector-mediated gene delivery in patient-derived GBM models. Patient-derived neurospheres (PDNS) and patient-derived tissue slice cultures (PDTC) were transduced with AAV2 or AAV6 vectors encoding green fluorescent protein (GFP). Transduction was evaluated by live confocal imaging, quantitative PCR, flow cytometry, and immunofluorescence under EGF-containing and EGF-free culture conditions. In PDNS, AAV6 produced significantly greater GFP expression than AAV2 and demonstrated a dose-dependent increase in transduction at both 2 and 5 days after vector exposure. EGF supplementation altered transduction patterns and was associated with changes in PDNS growth and marker-defined stem-like cell populations. In contrast, PDTC preserved tissue architecture and stromal, vascular, and immune-associated compartments while revealing substantial interpatient variability in AAV-mediated transduction. AAV-mediated gene delivery in GBM is influenced by culture model, growth factor conditions, and capsid serotype. Patient-derived tissue slice cultures complement neurosphere models by preserving features of the native tumor microenvironment and may improve the preclinical evaluation of gene therapy vectors for GBM.
Harmless amoeba’s tight-space crawling offers clues to how its deadly relative invades the brain
Tiny, shapeless invaders can find their way from ponds to the human brain and cause an infection so severe that it has a 95% fatality rate. The amoeba Naegleria fowleri naturally lives in ponds, feasting on bacteria, but once it enters the human body, it makes a run for the brain tissue, traversing complex, tight spaces to reach its destination.
A recent study set out to crack the secret of how a tiny amoeba steers itself through unfamiliar terrain without any guide.
Researchers built a microscopic obstacle course for the amoebas and filmed their every move, tracking how they squeeze through tight spaces and tackle different environments. They identified a few core mechanisms behind their navigational success. First, a love for tight spaces.
Electronic stripes linked to unusual vortex states in a superconductor
Superconductors, materials that can carry electric current with an electrical resistance of zero, have proved to be promising for the development of various technologies, including medical devices, particle accelerators and quantum computers. Studying these materials could help researchers uncover new physical states that could be useful for specific applications.
Magnetic fields can enter some superconductors, known as type-II superconductors, via regions called vortices. Each of these vortices carries a fixed amount of magnetic flux (i.e., a measure of the magnetic field passing through an area), with electrical currents circulating around its center.
Researchers at Tsinghua University, Southern University of Science and Technology, Boston College and other institutions investigated electronic states trapped near magnetic vortex centers in an iron-based superconductor.
Your favorite music could help reduce the pain of small medical procedures
If you hate needles, music might make you feel better during a cannula insertion—but it has to be the right kind of music. Although different musical interventions have repeatedly been reported to help with pain and stress, the evidence varies widely for different types of music, and it’s hard to figure out what works best. To investigate, scientists played different kinds of music for patients about to undergo an intravenous cannula insertion before an MRI—either Mozart, relaxation music or the patients’ own favorite tunes. They found that playing patients’ favorite music worked best.
“Although a needle puncture is a minor procedure, the level of pain can vary significantly from person to person,” said Dr. Andrei Cristinel Dragnea of University Hospital Zürich, lead author of the article in Frontiers in Pain Research. “In modern medicine, the goal of treating physicians is not only to provide a successful diagnosis and therapy, but also to ensure that the procedure causes as little discomfort as possible.”
“I would recommend listening to music to patients, especially patients who like music in general,” said Dr. Meritxell Garcia Alzamora of University Hospital Zürich, senior author of the article. “In view of our results, we will increase the application of music in venous punctures performed for radiological procedures, especially in anxious or claustrophobic patients.”
A trick from tardigrades could help human blood withstand freezing
Tardigrades survive conditions that would destroy most other living things: freezing, dehydration and the vacuum of space. Researchers even put tiny tattoos on them, and the animals don’t seem to mind. By learning how these critters carry on, researchers hope to find ways to protect human cells.
One potential application is red blood cell cryopreservation—a process that stores rare blood types for long periods until they are needed. Blood cells are typically treated with glycerol to stop ice crystal formation during freezing. But glycerol must be removed before a transfusion, which causes cell damage.
Tardigrades offer a simpler option: They have a protein called CAHS (cytosolic abundant heat-soluble) that they use to survive in extreme conditions. These proteins uniquely interact with trehalose, a sugar that stabilizes cell membranes and proteins. It’s often used to reduce freezer burn in frozen foods. So, Hui Yang, Leming Sun and colleagues wanted to explore whether combining CAHS proteins and trehalose could protect red blood cells in mice better than glycerol could alone.
Magnetic Nanoparticles Could Help Detect and Treat Dangerous Ectopic Pregnancies
Magnetic nanoparticles could eventually help doctors both locate and treat ectopic pregnancies, after successfully targeting pregnancy-associated tissue in mice.
When a fertilized egg implants inside a fallopian tube instead of the uterus, the growing pregnancy can rupture the tube and trigger life-threatening bleeding. About 98% of these abnormal implantations occur in the fallopian tubes, making early detection and treatment critical.
This condition, known as an ectopic pregnancy, occurs when a fertilized egg implants somewhere other than the lining of the uterus. These pregnancies cannot continue normally and remain a leading cause of maternal mortality during the first trimester.
Microglia Rescue Vulnerable Dopamine Neurons in Parkinson’s
Summary: Researchers at the University of Oxford have discovered that human microglia can selectively prune away toxic alpha-synuclein aggregates from dopamine-producing neurons without destroying the host nerve cells. Utilizing co-cultures of human induced pluripotent stem cell (iPSC)-derived neurons and microglia, the team demonstrated that microglia employ “trogocytosis”, a precise cellular nibbling mechanism, regulated by GPNMB, P2RY12, and CD22 signaling pathways, along with an IL-10 molecular brake. The findings identify a distinct, neuroprotective microglial subtype that shields neurons in Parkinson’s disease.









